Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kewaunee Scientific (KEQU) Share-based Compensation (2016 - 2026)

Kewaunee Scientific (KEQU) has 14 years of Share-based Compensation data on record, last reported at $561000.0 in Q4 2025.

  • For Q4 2025, Share-based Compensation rose 50.4% year-over-year to $561000.0; the TTM value through Oct 2025 reached $1.8 million, up 41.47%, while the annual FY2025 figure was $1.4 million, 40.18% up from the prior year.
  • Share-based Compensation reached $561000.0 in Q4 2025 per KEQU's latest filing, up from $521000.0 in the prior quarter.
  • Across five years, Share-based Compensation topped out at $561000.0 in Q4 2025 and bottomed at $129000.0 in Q1 2021.
  • Average Share-based Compensation over 5 years is $277200.0, with a median of $241000.0 recorded in 2023.
  • Peak YoY movement for Share-based Compensation: soared 2390.0% in 2021, then fell 27.19% in 2024.
  • A 5-year view of Share-based Compensation shows it stood at $150000.0 in 2021, then soared by 30.67% to $196000.0 in 2022, then grew by 22.96% to $241000.0 in 2023, then surged by 54.77% to $373000.0 in 2024, then soared by 50.4% to $561000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Share-based Compensation were $561000.0 in Q4 2025, $521000.0 in Q3 2025, and $370000.0 in Q2 2025.